A retrospective analysis of discontinuation rates and reasons for discontinuation in multiple sclerosis patients treated with delayed-release dimethyl fumarate (Biogen ONE Support Program)

被引：0
|
作者：
Vorobeychik, G. [1 ]
Potts, J. [2 ]
Smith, M. [3 ]
Vlaicu, M. [3 ]
机构：
[1] Fraser Hlth Multiple Sclerosis Clin, Burnaby, BC, Canada
[2] Biogen, Cambridge, MA USA
[3] Biogen, Mississauga, ON, Canada
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P638
引用
收藏
页码：301 / 302
页数：2
相关论文
共 50 条
  • [1] A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis
    Michelle Allan
    Lindsay Grant
    Neurology and Therapy, 2020, 9 : 85 - 92
  • [2] A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis
    Allan, Michelle
    Grant, Lindsay
    NEUROLOGY AND THERAPY, 2020, 9 (01) : 85 - 92
  • [3] Adherence and discontinuation rates in patients on Tecfidera™ (dimethyl fumarate): Long-term Canadian experience from the Biogen ONE™ support program
    Thompson, Mattea Tan
    Devonshire, Virginia
    Belviso, Nick
    Gillen, Melissa
    Engineer, Noella
    Shen, Changyu
    Reedie, Scott
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 67
  • [4] Lymphocyte Decline and Reconstitution After Discontinuation in Patients With Severe, Prolonged Lymphopenia Treated With Delayed-Release Dimethyl Fumarate
    Fox, Robert J.
    Chan, Andrew
    Gold, Ralf
    Phillips, J. Theodore
    Yang, Lili
    Liu, Shifang
    Chalkias, Spyros
    Mehta, Devangi
    Taylor, Catherine
    NEUROLOGY, 2018, 90
  • [5] Lymphocyte decline and reconstitution after discontinuation in patients with severe, prolonged lymphopenia treated with delayed-release dimethyl fumarate
    Fox, R. J.
    Chan, A.
    Gold, R.
    Phillips, J. T.
    Yang, L.
    Liu, S.
    Chalkias, S.
    Mehta, D.
    Taylor, C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 371 - 371
  • [6] Among real-world multiple sclerosis patients that experience delayed-release dimethyl fumarate-associated lymphopenia, meaningful lymphocyte reconstitution occurs within 3 months after discontinuation of delayed-release dimethyl fumarate
    Rose, J.
    Alvarez, E.
    Okuda, D.
    Gudesblatt, M.
    Riser, E.
    Spelman, T.
    Butzkueven, H.
    Fam, S.
    Riester, K.
    Wu, F.
    Miller, C.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 678 - 679
  • [7] Among Real-world Multiple Sclerosis Patients That Experience Delayed-release Dimethyl Fumarate-associated Lymphopenia, Meaningful Lymphocyte Reconstitution Occurs Approximately 3 Months After Discontinuation of Delayed-release Dimethyl Fumarate
    Rose, John
    Alvarez, Enrique
    Okuda, Darin
    Gudesblatt, Mark
    Riser, Emily
    Spelman, Timothy
    Fam, Sami
    Riester, Katherine
    Wu, Fan
    Miller, Catherine
    Butzkueven, Helmut
    NEUROLOGY, 2019, 92 (15)
  • [8] Effect of treating hospital on discontinuation rates of dimethyl fumarate in multiple sclerosis
    Norborg, H.
    Aarseth, J. H.
    Grytten, N.
    Mannseth, J.
    Myhr, K-M
    Sejbaek, T.
    Wergeland, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 893 - 893
  • [9] An interim analysis of quality of life in patients with relapsing-remitting multiple sclerosis treated with delayed-release dimethyl fumarate
    Sarda, S. P.
    Kita, M.
    Fox, R. J.
    Gold, R.
    Giovannoni, G.
    Phillips, T.
    Okwuokenye, M.
    Kong, J.
    Zhang, R.
    Kurukulasuriya, N. C.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 413 - 414
  • [10] Discontinuation Rates in Patients with Multiple Sclerosis treated with Dimethyl Fumarate between Clinics - a National Wide Cohort Study
    Roar, Malte
    Hogh, Amalie Rhode
    Illes, Zsolt Laszlo
    Magyari, Melinda
    Berg, Jonas
    Ratzer, Rikke
    Weglewski, Arkadiusz
    Jensen, Michael
    Asgari, Nasrin
    Kant, Matthias
    Sirakov, Georgi
    Theodorsdottir, Asta
    Stilund, Morten
    Schafer, Jakob
    Jensen, Henrik Boye
    Frederiksen, Jette Lautrup
    Sejbaek, Tobias
    NEUROLOGY, 2021, 96 (15)
12345